emeritusresearch.com

What It Is

Emeritus Research is a clinical trial research organization based in Australia, with main sites in Melbourne and Sydney. Its core clients are pharmaceutical companies, biotech companies, and clinical research sponsors, while it also allows the general public to register for clinical trial participation. The official website highlights more than 25 years of experience, 250+ clinical trials conducted, coverage across 30+ therapeutic areas, and recruitment of 8,000+ participants.

Core Features

Emeritus’s main value lies in helping sponsors run Phase I–IV outpatient clinical trials in Australia. Its capabilities cover study start-up, patient recruitment, pre-screening, on-site execution, data entry, and complex protocol management. Therapeutic areas include infectious diseases and vaccines, obesity and metabolic diseases, men’s, women’s, and sexual health, rheumatology, cardiovascular disease, dermatology and immunology, neurology, and mental health. Its exclusive partnership with Clinibase is a key selling point, enabling targeted digital recruitment and rigorous pre-screening to improve enrollment quality. The website also states that 98% of trials achieve data entry within 24 hours, helping sponsors gain faster visibility into study progress.

Pricing

The official website does not publish pricing. Clinical trial services are highly customized, and costs usually depend on the study phase, protocol complexity, sample size, number of sites, follow-up duration, testing requirements, and regulatory demands. Enterprise clients need to contact the team directly for protocol assessment and a quote.

Pros and Cons

Its strengths include deep local experience in Australia, especially a strong track record in vaccine research; strong recruitment capabilities, with multiple case studies showing its ability to complete large-scale enrollment in a short period; fast data turnaround; and the ability to handle complex projects involving GLP-1, HPV, influenza vaccines, atopic dermatitis, and more. Its drawbacks are that its sites are concentrated in Melbourne and Sydney, giving it less geographic coverage than large global CROs; the website provides limited disclosure on certifications, quality systems, and full PI profiles; and there is no public pricing, making upfront cost comparison more difficult.

Who It’s For

It is suitable for pharmaceutical companies, biotech companies, vaccine developers, and CRO partners looking to conduct clinical research in Australia, especially projects that prioritize rapid recruitment, Australian regulatory pathways, R&D tax incentives, and high-quality outpatient trial execution. Ordinary Australian residents can also participate in clinical trials through its channels.

Access from China

The website can generally be accessed directly from mainland China, but its services are Australia-based clinical research services and are not intended for local medical services or patient recruitment in China. Chinese pharmaceutical companies planning overseas expansion or early- and late-stage research in Australia can evaluate it as a local execution partner.